ApprovalTrail

Approval · Notice of Compliance 10507 · 2009

BARACLUDE: Notice of Compliance 10507

Issued August 14, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
10507
Date
August 14, 2009
Company
Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Updates to the product monograph
Therapeutic class
Antiviral

Products in this notice

BrandDINStatus today
BARACLUDENot yet assigned—

Medicinal ingredients